Detalhe da pesquisa
1.
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Pharmacol Res
; 194: 106859, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37473877
2.
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort.
Int J Mol Sci
; 24(2)2023 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36675312
3.
Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease.
Br J Clin Pharmacol
; 87(2): 447-457, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32478906
4.
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease.
J Pediatr Gastroenterol Nutr
; 71(4): 508-515, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32773718
5.
Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.
Int J Mol Sci
; 21(9)2020 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32397546
6.
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Pharmacol Res
; 196: 106938, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748560
7.
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.
Biomed Pharmacother
; 173: 116299, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38401525
8.
Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.
Pharmaceutics
; 13(1)2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33429950
9.
[Clinical applications of the use of probiotics in pediatrics]. / Aplicaciones clínicas del empleo de probióticos en pediatría.
Nutr Hosp
; 28(3): 564-74, 2013.
Artigo
em Espanhol
| MEDLINE | ID: mdl-23848073